AI for Health Summit 2023
HOME
REPLAYS
SPEAKERS
EXHIBITORS
ABOUT US
JOIN AS A MEMBER
PAST EVENTS & ECOSYSTEM
TICKETS
Join session
🇫🇷 AI Act & Garantie Humaine : quelles cartes à jouer pour innover ?
Nov 22, 2023
—
02:35 pm CET
-
2:55 PM CET
Presented by
DGP
Dr Grégoire
Pigné
PulseLife
Oncologist Radiotherapist, Co-founder...
KL
Katya
Lainé
Numeum
Administrator, President of the AI...
JM
Judith
Mehl
Ethik-IA
Co-founder & Managing Director
MS
Marine
Sortais
Artefact
Data Consulting Director
Presented
by
KL
Katya
Lainé
Administrator, President of the AI Commission
JM
Judith
Mehl
Co-founder & Managing Director
DGP
Dr Grégoire
Pigné
Oncologist Radiotherapist, Co-founder and CEO
MS
Marine
Sortais
Data Consulting Director
In
partnership
with
1
22
Suggested
sessions
Nov 22nd
9:00 am
-
9:25 am
Mainstage
🇬🇧 AI for Health 6th edition kick start
JN
Justine
Nerce
Artefact
Managing partner and global industry lead for healthcare
DG
Damien
Gromier
AI for Health
Founder
DA
Delphine
Aguiléra-Caron
Johnson & Johnson Innovative Medicine France
Managing Director
Nov 22nd
9:25 am
-
9:50 am
Mainstage
🇬🇧 Virtual cohort, but real recognition by payers?
RP
Raphaelle
Parker
Johnson & Johnson Innovative Medicine
Principal Scientist
PSA
Pr Stéphanie
Allassonnière
Paris Cité University
Chair PR[AI]RIE & Professor
PRP
Pr Raphaël
Porcher
AP-HP
Professor of Biostatistics
YLD
Yann-Mael
Le Douarin
French Ministry of Health & Prevention
Medical Advisor e-Health
DJF
Dr Jean-Louis
Fraysse
BOTdesign
Co-founder
Nov 22nd
9:30 am
-
9:50 am
Corporate Masterclass Stage
🇫🇷 Accès au marché DM embarquant de l’IA en santé mentale :​ quelques questions à se poser ?​
VV
Vincent
Vercamer
French Ministry of Health & Prevention
Project Director – Market Access expert, Digital Health Delegation
DLF
Dr Line
Farah
French Ministry of Health & Prevention
Director of Digital Health Challenges for "Mental health" and "Aging well", Digital Health Delegation
Nov 22nd
9:30 am
-
9:40 am
Startups Masterclass Stage
🇬🇧 Oncogenomics + AI :Transcriptomics signatures to allow prognosis and targeted therapy in...
JJ
Jean-Baptiste
JAUSSAUD
Predicting Med
CEO